Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Scandinavian Journal of Haematology
|
November 1, 1985
Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma
G Brenning, A Ahre, K Nilsson
European Journal of Clinical Investigation
|
August 1, 1987
Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myeloma
B Simonsson, G Brenning, C Källander, et al.
British Journal of Haematology
|
January 1, 1986
Pretreatment serum beta 2-microglobulin in multiple myeloma
G Brenning, B Simonsson, C Källander, et al.
International Journal of Cancer
|
August 15, 1982
Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha
S Einhorn, A Ahre, H Blomgren, et al.
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology
|
August 1, 1984
IgA subclass distribution in paraproteinemias: suggestion of an IgG-IgA subclass switch pattern
L Hammarström, H Mellstedt, M A Persson, et al.
Lancet (London, England)
|
February 3, 1979
Interferon therapy in myelomatosis
H Mellstedt, A Ahre, M Björkholm, et al.
British Journal of Haematology
|
October 1, 1985
Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma
B Simonsson, C F Källander, G Brenning, et al.
European Journal of Haematology
|
February 1, 1987
Blood clonal B cell excess at diagnosis in multiple myeloma: relation to prognosis
A Osterborg, B Nilsson, M Björkholm, et al.
Scandinavian Journal of Haematology
|
July 1, 1982
T cells in monoclonal gammopathies
H Mellstedt, G Holm, D Pettersson, et al.
Scandinavian Journal of Haematology
|
July 1, 1985
Alpha interferon treatment of patients with hairy-cell leukaemia
H Hagberg, G Alm, M Björkholm, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Scandinavian Journal of Haematology
|
November 1, 1985
Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma
G Brenning, A Ahre, K Nilsson
European Journal of Clinical Investigation
|
August 1, 1987
Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myeloma
B Simonsson, G Brenning, C Källander, et al.
British Journal of Haematology
|
January 1, 1986
Pretreatment serum beta 2-microglobulin in multiple myeloma
G Brenning, B Simonsson, C Källander, et al.
International Journal of Cancer
|
August 15, 1982
Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha
S Einhorn, A Ahre, H Blomgren, et al.
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology
|
August 1, 1984
IgA subclass distribution in paraproteinemias: suggestion of an IgG-IgA subclass switch pattern
L Hammarström, H Mellstedt, M A Persson, et al.
Lancet (London, England)
|
February 3, 1979
Interferon therapy in myelomatosis
H Mellstedt, A Ahre, M Björkholm, et al.
British Journal of Haematology
|
October 1, 1985
Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma
B Simonsson, C F Källander, G Brenning, et al.
European Journal of Haematology
|
February 1, 1987
Blood clonal B cell excess at diagnosis in multiple myeloma: relation to prognosis
A Osterborg, B Nilsson, M Björkholm, et al.
Scandinavian Journal of Haematology
|
July 1, 1982
T cells in monoclonal gammopathies
H Mellstedt, G Holm, D Pettersson, et al.
Scandinavian Journal of Haematology
|
July 1, 1985
Alpha interferon treatment of patients with hairy-cell leukaemia
H Hagberg, G Alm, M Björkholm, et al.
Page
of 2